Liver cancer remains among the leading causes of cancer-related death worldwide.
New study lead by UAE University Prof. Amr Amin unravels mechanisms by which saffron-based 'crocin' protects against liver cancer.
The study entitled 'Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In Vivo, In Vitro and Network Analyses' is funded by Al-Jalila Foundation & Terry Fox Foundation and is published in Recent Patents on Anticancer Drug Discovery.
Using murine model, human liver cancer cells, gene expression profiling and computer-assisted modelling analyses, Amin's study identifies NF-kB as a regulatory hub and a candidate therapeutic drug target for liver cancer.
Source: Bentham Science Publishers
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.